FIELD: medicine, pharmaceutics.
SUBSTANCE: invention aims at a controlled release composition for an oral solid dosage form. The composition contains mixed hypromellose and polyvinylacetatephthalate. An amount of hypromellose makes 8 to 60 wt %, an amount of polyvinylacetatephthalate is effective for maintaining controlled release of a pharmaceutically active ingredient in vitro and makes 4 to 60 wt % of the mixture. Said mixture of hypromellose and polyvinylacetatephthalate is pressed in a swelling hydrophilic matrix.
EFFECT: invention enables controlled release of the combined pharmaceutically active ingredient.
25 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS WITH CONTROLLED RELEASE OF ALFUZOSIN | 2006 |
|
RU2423107C2 |
COMPOSITION WITH ARIMOCLOMOL | 2015 |
|
RU2745292C2 |
CONTROLLED-RELEASE PHARMACEUTICAL TABLET FOR ORAL ADMINISTRATION METHODS FOR PREPARATION THEREOF | 2011 |
|
RU2603469C2 |
IMMEDIATE RELEASE COMPOSITIONS | 2010 |
|
RU2541807C2 |
ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMS | 2014 |
|
RU2679448C2 |
SOLID DOSAGE FORMS OF ONDANSETRON WITH PROLONGED RELEASE FOR TREATING SYMPTOMS OF NAUSEA, VOMITING AND DIARRHEA | 2015 |
|
RU2706708C2 |
TAMZULOSIN TABLETS | 2002 |
|
RU2311903C2 |
SOLID DISPERSIONS | 2016 |
|
RU2694832C2 |
SYSTEM FOR PROLONGED RELEASE OF SOLUBLE DRUG | 2002 |
|
RU2322263C2 |
MATRIX TABLET WITH MODIFIED NERAMEXANE RELEASE | 2006 |
|
RU2422135C2 |
Authors
Dates
2011-03-20—Published
2006-08-25—Filed